Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANDREA-LD antipsychotic reduction trial
2013-000389-12Phase 4Completed
- Sponsor
- Cardiff University
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of haloperidol and risperidone in challenging behavior and Aggression (not a disease; see rationale) (2 arms), sponsored by Cardiff University. Primary endpoint: Aggression. Started Jul 2013; status: completed.
02
Drugs
haloperidolrisperidone
03
Conditions
challenging behaviorAggression (not a disease; see rationale)
Beyond the preview
Go deeper on 2013-000389-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000389-12.